Effectiveness of High Dose Remifentanil in Preventing Coughing and Laryngospasm in Non-paralyzed Patients for Advanced Bronchoscopic Procedures

Overview

Journal Ann Thorac Med

Specialty Pulmonary Medicine

Date 2014 Feb 20

PMID 24551014

Citations 4

Authors

Basavana Gouda Goudra

Preet Mohinder Singh

Amit K Manjunath

Joel W Reihmer

Andrew R Haas

Anthony R Lanfranco

Ashish C Sinha

Kassem Harris

Affiliations

Soon will be listed here.

Abstract

Background: Anesthesia for bronchoscopy presents unique challenges, as constant stimulus due to bronchoscope needs to be obtunded using drugs with a minimal post-procedure residual effect. Remifentanil for maintenance is an ideal choice, but optimal doses are yet to be determined.

Materials And Methods: Bronchoscopic procedures were prospectively evaluated for 4 months studying the frequency of complications and anesthesia techniques. Anesthesia was maintained on remifentanil/propofol infusion avoiding neuromuscular blockers. Laryngeal mask airway was used for the controlled ventilation (with high oxygen concentration) that also served as a conduit for bronchoscope insertions. Anesthesiologists were blinded to the study (avoiding performance bias) and the Pulmonologist was blinded to the anesthesia technique (to document unbiased procedural satisfaction scores). Procedures were divided into 2 groups based on the dose of remifentanil used for maintenance: Group-H (high dose -0.26 to 0.5 μg/kg/min and Group-NH (non-high dose ≤0.25 μg/kg/min).

Results: Observed 75 procedures were divided into Group-H (42) and Group-NH (33). Number of statistical difference was found in demography, procedural profile, hemodynamic parameters and total phenylephrine used. Chi-square test showed Group-NH had significantly higher frequency of laryngospasm (P = 0.047) and coughing (P = 0.002). The likelihood ratio of patient coughing and developing laryngospasm in Group-NH was found to be 4.56 and 10.97 times respectively. Minimum pulse-oximeter saturation was statistically higher in Group-H (98.80% vs. 96.50% P = 0.009). Pulmonologist satisfaction scores were significantly better in Group-H.

Conclusions: High dose of remifentanil infusion is associated with a lower incidence of coughing and laryngospasms during bronchoscopy. Simultaneously, it improves Pulmonologist's satisfaction and procedural conditions.

Citing Articles

Flexible bronchoscopy in a tertiary healthcare facility: a review of indications and outcomes.

Afriyie-Mensah J, Kwarteng E, Tetteh J, Sereboe L, Forson A Ghana Med J. 2024; 55(1):18-25.

PMID: 38322384 PMC: 10665266. DOI: 10.4314/gmj.v55i1.4.

Inhibition of stress and spontaneous respiration: Efficacy and safety of monitored anesthesia care by target-controlled infusion remifentanil in combination with dexmedetomidine in fibreoptic bronchoscopy for patients with severe tracheal stenosis.

Zhou Y, Wu W, Zhu Y, Lv X, Liu J Front Med (Lausanne). 2022; 9:972066.

PMID: 36388940 PMC: 9659885. DOI: 10.3389/fmed.2022.972066.

Dexmedetomidine facilitates extubation in children who require intubation and respiratory support after airway foreign body retrieval: a case-cohort analysis of 57 cases.

Zhang X, Wu J, Wang L, Li W J Anesth. 2018; 32(4):592-598.

PMID: 29948375 DOI: 10.1007/s00540-018-2519-3.

Anesthesia for Advanced Bronchoscopic Procedures: State-of-the-Art Review.

Goudra B, Singh P, Borle A, Farid N, Harris K Lung. 2015; 193(4):453-65.

PMID: 25921014 DOI: 10.1007/s00408-015-9733-7.

References

Chalumeau-Lemoine L, Stoclin A, Billard V, Laplanche A, Raynard B, Blot F . Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study. Intensive Care Med. 2012; 39(1):53-8. DOI: 10.1007/s00134-012-2697-7. View

Weingarten T, Kor D, Gali B, Sprung J . Predicting postoperative pulmonary complications in high-risk populations. Curr Opin Anaesthesiol. 2013; 26(2):116-125. PMC: 4844023. DOI: 10.1097/ACO.0b013e32835e21d2. View

Canet J, Gallart L, Gomar C, Paluzie G, Valles J, Castillo J . Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010; 113(6):1338-50. DOI: 10.1097/ALN.0b013e3181fc6e0a. View

Yeganeh N, Roshani B, Azizi B, Almasi A . Target-controlled infusion of remifentanil to provide analgesia for awake nasotracheal fiberoptic intubations in cervical trauma patients. J Trauma. 2010; 69(5):1185-90. DOI: 10.1097/TA.0b013e3181cb4434. View

Quintard H, Pavlakovic I, Mantz J, Ichai C . Adjunctive remifentanil infusion in deeply sedated and paralyzed ICU patients during fiberoptic bronchoscopy procedure: a prospective, randomized, controlled study. Ann Intensive Care. 2012; 2(1):29. PMC: 3487977. DOI: 10.1186/2110-5820-2-29. View

Goudra B, Singh P, Sinha A . Anesthesia for ERCP: Impact of Anesthesiologist's Experience on Outcome and Cost. Anesthesiol Res Pract. 2013; 2013:570518. PMC: 3679699. DOI: 10.1155/2013/570518. View

HALL A, Thompson J, Leslie N, Fox A, Kumar N, Rowbotham D . Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation. Br J Anaesth. 2000; 84(1):100-2. DOI: 10.1093/oxfordjournals.bja.a013362. View

Zhang J, Wang Y, Li B, Zhang W . Remifentail infusion for paediatric bronchoscopic foreign body removal: comparison of sevoflurane with propofol for anaesthesia supplementation for bronchoscope insertion. Anaesth Intensive Care. 2010; 38(5):905-10. DOI: 10.1177/0310057X1003800431. View

McAlister F, Bertsch K, Man J, Bradley J, Jacka M . Incidence of and risk factors for pulmonary complications after nonthoracic surgery. Am J Respir Crit Care Med. 2004; 171(5):514-7. DOI: 10.1164/rccm.200408-1069OC. View

10.

Natalini G, Fassini P, Seramondi V, Amicucci G, Toninelli C, Cavaliere S . Remifentanil vs. fentanyl during interventional rigid bronchoscopy under general anaesthesia and spontaneous assisted ventilation. Eur J Anaesthesiol. 1999; 16(9):605-9. DOI: 10.1046/j.1365-2346.1999.00548.x. View

11.

Teksan L, Baris S, Karakaya D, Dilek A . A dose study of remifentanil in combination with propofol during tracheobronchial foreign body removal in children. J Clin Anesth. 2013; 25(3):198-201. DOI: 10.1016/j.jclinane.2012.10.008. View

12.

Facciolongo N, Patelli M, Gasparini S, Agli L, Salio M, Simonassi C . Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies. Monaldi Arch Chest Dis. 2009; 71(1):8-14. DOI: 10.4081/monaldi.2009.370. View

13.

Berkenbosch J, Graff G, Stark J, Ner Z, Tobias J . Use of a remifentanil-propofol mixture for pediatric flexible fiberoptic bronchoscopy sedation. Paediatr Anaesth. 2004; 14(11):941-6. DOI: 10.1111/j.1460-9592.2004.01355.x. View

14.

Reyle-Hahn M, Niggemann B, Max M, Streich R, Rossaint R . Remifentanil and propofol for sedation in children and young adolescents undergoing diagnostic flexible bronchoscopy. Paediatr Anaesth. 2000; 10(1):59-63. DOI: 10.1046/j.1460-9592.2000.00440.x. View

15.

Ryu J, Lee S, Lee J, Lee E, Do S, Kim C . Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. Br J Anaesth. 2011; 108(3):503-11. DOI: 10.1093/bja/aer400. View

16.

Goudra B, Singh P, Sinha A . Outpatient endoscopic retrograde cholangiopancreatography: Safety and efficacy of anesthetic management with a natural airway in 653 consecutive procedures. Saudi J Anaesth. 2013; 7(3):259-65. PMC: 3757797. DOI: 10.4103/1658-354X.115334. View

17.

LUKOMSKY G, Ovchinnikov A, Bilal A . Complications of bronchoscopy: comparison of rigid bronchoscopy under general anesthesia and flexible fiberoptic bronchoscopy under topical anesthesia. Chest. 1981; 79(3):316-21. DOI: 10.1378/chest.79.3.316. View